Enhanced Urease-Driven Nanobots for Radionuclide-Based Bladder Cancer Therapy

S. Mohammed Sahil*, S. Atheena Milagi Pandian**, Rashika Murugan***
*-*** Atheenapandian Private Limited, India.
Periodicity:January - March'2024
DOI : https://doi.org/10.26634/jms.11.4.20821

Abstract

Bladder cancer treatment with intravenous medication delivery has reasonable survival rates but modest therapeutic efficacy. Taking advantage of their superior diffusion and mixing capacities in urine compared to traditional pharmaceuticals or passive nanoparticles, self-propelled nanoparticles, also known as nanobots, have been proposed as a solution to the latter issue. Nonetheless, nothing is known about how well nanobots can translate into bladder cancer treatments. Here, urease-powered, radiolabelled mesoporous silica-based nanobots were evaluated in an orthotopic animal model of bladder cancer. Both in vivo and ex vivo findings showed increased accumulation of nanobots at the tumor location; positron emission tomography in vivo showed an eight-fold increase. The ex vivo tumor penetration by nanobots was validated by label-free optical contrast based on polarization-dependent scattered light-sheet microscopy of cleared bladders. Intravesically treatment was given to tumor-bearing mice. About 90% less tumor size was observed when radio-iodinated nanobots were used for radionuclide therapy, establishing nanobots as effective delivery nanosystems for bladder cancer treatment.

Keywords

Nanorobots, Nanobots, Treatment, Cancer Therapy, Bladder Cancer, Orthotopic.

How to Cite this Article?

Sahil, S. M., Pandian, S. A. M., and Murugan, R. (2024). Enhanced Urease-Driven Nanobots for Radionuclide-Based Bladder Cancer Therapy. i-manager’s Journal on Material Science, 11(4), 8-14. https://doi.org/10.26634/jms.11.4.20821

References

[19]. Seidl, C. (2020). Targets for therapy of bladder cancer. In Seminars in Nuclear Medicine, 50(2), pp. 162-170. WB Saunders.
[20]. Simó, C., Serra-Casablancas, M., Hortelao, A. C., Di Carlo, V., Guallar-Garrido, S., Plaza-García, S., ... & Sánchez, S. (2024). Urease-powered nanobots for radionuclide bladder cancer therapy. Nature Nanotechnology, 1-11.
[21]. Chinol, M., De Cobelli, O., Trifirò, G., Scardino, E., Bartolomei, M., Verweij, F., ... & Paganelli, G. (2003). Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy. European Urology, 44(5), 556-559.
If you have access to this article please login to view the article or kindly login to purchase the article

Purchase Instant Access

Single Article

North Americas,UK,
Middle East,Europe
India Rest of world
USD EUR INR USD-ROW
Online 15 15

Options for accessing this content:
  • If you would like institutional access to this content, please recommend the title to your librarian.
    Library Recommendation Form
  • If you already have i-manager's user account: Login above and proceed to purchase the article.
  • New Users: Please register, then proceed to purchase the article.